No Prescription |
 |
 | ||
|
ENCRIPT Parlodel |
|
| ||
No Prescription » Prescription Drugs 7 » ENCRIPT Parlodel Bromocriptine is used to treat amenorrhea a condition in which the menstrual period does not occur; infertility (inability to get pregnant) in women; abnormal discharge of milk from the breast; hypogonadism; Parkinson's disease; and acromegaly a condition in which too much growth hormone is in the body.Bromocriptine comes as a capsule and tablet to take by mouth. It usually is taken once or twice a day. It also may be taken several times a day to treat certain conditions. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take bromocriptine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Do not stop taking bromocriptine suddenly without talking with your doctor. It could make your condition worse.If you are taking bromocriptine for amenorrhea it usually takes 6-8 weeks for a menstrual period to occur. If you are taking bromocriptine to become pregnant use a method of birth control other than oral contraceptives (birth control pills) until you have regular menstrual periods; then stop using birth control. If your menstrual period is 3 days late call your doctor for a pregnancy test. Women who become pregnant while taking this medication should stop taking it and call their doctors immediately. If you do not wish to become pregnant use a method of birth control other than oral contraceptives while taking bromocriptine.Bromocriptine is also used to treat certain tumors in men and women a condition called neuroleptic malignant syndrome; cocaine addiction; and a painful breast condition. Buy ENCRIPT Parlodel and other Prescription Drugs 7 products online at Medstore. 395
About ENCRIPT Parlodel: Product Type: Prescription Drugs 7 ENCRIPT ( Parlodel Generic Bromocriptine ) ENCRIPT (Parlodel Generic Bromocriptine) Parlodel Generic Bromocriptine 2.5mg Tabs 100 (10 x 10) Parlodel Generic Bromocriptine ENCRIPT
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
